CNC

63.7802.74%
SM

Sarah M. London

CEO & Director

Ms. Sarah M. London has been the Chief Executive Officer of Centene Corporation since March 21, 2022 and serves as its Director since September 2021. She served as President of Health Care Enterprises and Executive VP of Advanced Technology at Centene Corporation since March 2021 until September 2021 and served as its Vice Chairman of the Board since September 2021 until March 21, 2022 and served as its Senior Vice President of Technology Innovation & Modernization since September 2020 until March 2021. Ms. London continues to be responsible for Health Care Enterprises and Advanced Technology and set strategy and have responsibility for Technology, Business Digitalization, Corporate Strategy, Quality Operations, Internal Audit, Compliance and Enterprise Risk Management. Prior to joining Centene, she served as both Senior Principal and Partner for Optum Ventures from May 2018 to March 2020 and Chief Product Officer of Optum Analytics from March 2016 to May 2018, working on product strategy and expansion. From March 2014 to March 2016, she served as Vice President, Client Management and Operations for Humedica. Prior to joining Humedica, Ms. London was part of the team that launched Accretive Health's Quality & Total Cost of Care business, providing end-to-end population health strategy and operational consulting to leading medical centers around the country. Ms. London began her healthcare career at Health Leads. Ms. London received an M. B. A. with High Honors from the University of Chicago Booth School of Business and a B. A. Magna Cum Laude in History & Literature from Harvard College.

Positions